Breast cancer management in the era of Covid-19; key issues, contemporary strategies, and future implications
AHMSU Prodhan, DZ Islam, SS Khandker… - … Cancer: Targets and …, 2023 - Taylor & Francis
During the COVID-19 pandemic, several priority diseases were not getting sufficient
attention. Whilst breast cancer is a fatal disease affecting millions worldwide, identification …
attention. Whilst breast cancer is a fatal disease affecting millions worldwide, identification …
Management of adverse events and supportive therapy in relapsed/refractory multiple myeloma
S Pozzi, A Bari, M Pecherstorfer, S Vallet - Cancers, 2021 - mdpi.com
Simple Summary Multiple myeloma (MM) patients with relapsing and/or refractory (RR)
disease are exposed for a prolonged time to multiple drugs, which increase the risk of …
disease are exposed for a prolonged time to multiple drugs, which increase the risk of …
[HTML][HTML] Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice …
R von Moos, K Lewis, L Massey, A Marongiu, A Rider… - Bone, 2022 - Elsevier
Background Guidelines recommend starting bone-targeted agents (BTA), such as
zoledronic acid and denosumab, as soon as bone metastases (BMs) are definitively …
zoledronic acid and denosumab, as soon as bone metastases (BMs) are definitively …
Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement
R Coropciuc, C Moreno-Rabié, W De Vos… - Acta Chirurgica …, 2024 - Taylor & Francis
Objectives To provide a critical update identifying the knowledge gaps and controversies in
medication-related osteonecrosis of the jaw (MRONJ) within the Belgian healthcare context …
medication-related osteonecrosis of the jaw (MRONJ) within the Belgian healthcare context …
Associations between new health conditions and healthcare service utilizations among older adults in the United Kingdom: effects of COVID-19 risks, worse financial …
B Han, H Guan - BMC geriatrics, 2022 - Springer
Background Health services are critically important for older adults, particularly during the
Coronavirus disease-19 (COVID-19) pandemic. However, COVID-19 risks, worse financial …
Coronavirus disease-19 (COVID-19) pandemic. However, COVID-19 risks, worse financial …
[HTML][HTML] Adoption of adjuvant bisphosphonates for early breast cancer into standard clinical practice: Challenges and lessons learnt from comparison of the UK and …
I Porter, E Theodoulou, I Holen, C Harper-Wynne… - Journal of Bone …, 2021 - Elsevier
International guidelines recommend adjuvant bisphosphonates (BPs) for post-menopausal
women with early breast cancer to reduce recurrence and mortality. However, globally, wide …
women with early breast cancer to reduce recurrence and mortality. However, globally, wide …
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: implications for bone health
NL Barclay, M Catala, AM Jodicke, D Prieto-Alhambra… - medRxiv, 2023 - medrxiv.org
Background: The COVID-19 pandemic affected cancer screening, diagnosis and treatment
pathways. This study examined the impact of the pandemic on incidence and trends of …
pathways. This study examined the impact of the pandemic on incidence and trends of …
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study
NL Barclay, M Català, AM Jödicke… - Therapeutic …, 2024 - journals.sagepub.com
Background: The COVID-19 pandemic affected cancer screening, diagnosis and treatments.
Many surgeries were substituted with bridging therapies during the initial lockdown, yet …
Many surgeries were substituted with bridging therapies during the initial lockdown, yet …
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023
KJ Knight, RJ Fordham, NJ Crabtree… - Osteoporosis …, 2024 - Springer
This study uses NHS waiting times and osteoporosis medication community prescription
datasets to assess the impact of COVID-19 on DXA waits and osteoporosis medication …
datasets to assess the impact of COVID-19 on DXA waits and osteoporosis medication …
Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic
B Bogaert, V Buisson, Z Kozlakidis… - Critical Reviews in …, 2022 - Elsevier
This scoping review mapped the main themes in existing expert guidelines for cancer care
issued during the COVID-19 crisis from the period of March 2020-August 2021. The …
issued during the COVID-19 crisis from the period of March 2020-August 2021. The …